Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital
Overall, 94 patients underwent coronary angiography with the intent of PCI (of whom 88 received >1 stent or balloon angioplasty) for ST-segment elevation myocardial infarction (STEMI) in 49 patients, non-ST-segment elevation acute coronary syndromes (ACS) in 38, and stable angina in 7. Â Single-C...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2017-01, Vol.69 (4), p.463-464 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 464 |
|---|---|
| container_issue | 4 |
| container_start_page | 463 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 69 |
| creator | Vaduganathan, Muthiah Qamar, Arman Singh, Abhayjit Venkateswaran, Ramkumar V. Szumita, Paul M. Croce, Kevin J. Mauri, Laura Leopold, Jane A. Shah, Pinak B. Sobieszczyk, Piotr Faxon, David P. Bhatt, Deepak L. |
| description | Overall, 94 patients underwent coronary angiography with the intent of PCI (of whom 88 received >1 stent or balloon angioplasty) for ST-segment elevation myocardial infarction (STEMI) in 49 patients, non-ST-segment elevation acute coronary syndromes (ACS) in 38, and stable angina in 7.  Single-Center Real-World Experience (n = 100) Pooled CHAMPION Trials[low *] (n = 12,475) Demographic characteristics   Age, yrs 64.0 (55-73) 63.0 (55-71) Female 31 27.6 Medical history   Diabetes mellitus 30 29.3 Prior stroke or transient ischemic attack 6 5.2 History of heart failure 13 8.7 History of peripheral artery disease 11 7.1 Indication for cangrelor use   ST-segment elevation myocardial infarction 49 11.3 Non-ST-segment elevation acute coronary syndrome 38 57.3 Stable angina 7 31.4 Other 6 0 Patient presentation   Cardiogenic shock 16 -- |
| doi_str_mv | 10.1016/j.jacc.2016.11.017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1868323999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109716369339</els_id><sourcerecordid>1846026626</sourcerecordid><originalsourceid>FETCH-LOGICAL-e325t-9718831502eb81e824eb7c92725899b5166605720cec99a07b7a09d4d01b3f433</originalsourceid><addsrcrecordid>eNqNkc1u1TAQhS1ERW8LL8ACWWLDogkeO7ZjxOYq9AepEhK0Ymk5zrRy5JsEO7eCt-mz8GQktN2wYjWj0TdHM-cQ8hpYCQzU-77snfclX_oSoGSgn5ENSFkXQhr9nGyYFrIAZvQhOcq5Z4ypGswLcsi1gUoZsyHYuOE2YRwTvc5Iv4XBIz37tP19v52mNN65-IFu1_FtxKLBYcZ0Qr-ii8X3McWOnv6cMAVct9xMHb3CNAeXftHGJaQXY57C7OJLcnDjYsZXj_WYXJ-dXjUXxeWX88_N9rJAweVcGA11LUAyjm0NWPMKW-0N11zWxrQSlFJMas48emMc0612zHRVx6AVN5UQx-Tdg-5y-o895tnuQvYYoxtw3GcLtaoFF8aY_0ArxbhSXC3o23_QftynYXlkFRRSCaZgod48Uvt2h52dUtgtRtgnrxfg4wOAiwN3AZPN_q9zXUjoZ9uNwQKza7S2t2u0do3WAtglWvEHSmGS2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1863563061</pqid></control><display><type>article</type><title>Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital</title><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Vaduganathan, Muthiah ; Qamar, Arman ; Singh, Abhayjit ; Venkateswaran, Ramkumar V. ; Szumita, Paul M. ; Croce, Kevin J. ; Mauri, Laura ; Leopold, Jane A. ; Shah, Pinak B. ; Sobieszczyk, Piotr ; Faxon, David P. ; Bhatt, Deepak L.</creator><creatorcontrib>Vaduganathan, Muthiah ; Qamar, Arman ; Singh, Abhayjit ; Venkateswaran, Ramkumar V. ; Szumita, Paul M. ; Croce, Kevin J. ; Mauri, Laura ; Leopold, Jane A. ; Shah, Pinak B. ; Sobieszczyk, Piotr ; Faxon, David P. ; Bhatt, Deepak L.</creatorcontrib><description>Overall, 94 patients underwent coronary angiography with the intent of PCI (of whom 88 received >1 stent or balloon angioplasty) for ST-segment elevation myocardial infarction (STEMI) in 49 patients, non-ST-segment elevation acute coronary syndromes (ACS) in 38, and stable angina in 7.  Single-Center Real-World Experience (n = 100) Pooled CHAMPION Trials[low *] (n = 12,475) Demographic characteristics   Age, yrs 64.0 (55-73) 63.0 (55-71) Female 31 27.6 Medical history   Diabetes mellitus 30 29.3 Prior stroke or transient ischemic attack 6 5.2 History of heart failure 13 8.7 History of peripheral artery disease 11 7.1 Indication for cangrelor use   ST-segment elevation myocardial infarction 49 11.3 Non-ST-segment elevation acute coronary syndrome 38 57.3 Stable angina 7 31.4 Other 6 0 Patient presentation   Cardiogenic shock 16 --</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2016.11.017</identifier><identifier>PMID: 27914699</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute coronary syndromes ; Angina pectoris ; Blood platelets ; Cardiology ; Drug dosages ; Electrocardiography ; FDA approval ; Glycoproteins ; Heart attacks ; Patients ; Stents ; Surgery ; Thrombosis</subject><ispartof>Journal of the American College of Cardiology, 2017-01, Vol.69 (4), p.463-464</ispartof><rights>2017 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Jan 31, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2016.11.017$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27914699$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vaduganathan, Muthiah</creatorcontrib><creatorcontrib>Qamar, Arman</creatorcontrib><creatorcontrib>Singh, Abhayjit</creatorcontrib><creatorcontrib>Venkateswaran, Ramkumar V.</creatorcontrib><creatorcontrib>Szumita, Paul M.</creatorcontrib><creatorcontrib>Croce, Kevin J.</creatorcontrib><creatorcontrib>Mauri, Laura</creatorcontrib><creatorcontrib>Leopold, Jane A.</creatorcontrib><creatorcontrib>Shah, Pinak B.</creatorcontrib><creatorcontrib>Sobieszczyk, Piotr</creatorcontrib><creatorcontrib>Faxon, David P.</creatorcontrib><creatorcontrib>Bhatt, Deepak L.</creatorcontrib><title>Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>Overall, 94 patients underwent coronary angiography with the intent of PCI (of whom 88 received >1 stent or balloon angioplasty) for ST-segment elevation myocardial infarction (STEMI) in 49 patients, non-ST-segment elevation acute coronary syndromes (ACS) in 38, and stable angina in 7.  Single-Center Real-World Experience (n = 100) Pooled CHAMPION Trials[low *] (n = 12,475) Demographic characteristics   Age, yrs 64.0 (55-73) 63.0 (55-71) Female 31 27.6 Medical history   Diabetes mellitus 30 29.3 Prior stroke or transient ischemic attack 6 5.2 History of heart failure 13 8.7 History of peripheral artery disease 11 7.1 Indication for cangrelor use   ST-segment elevation myocardial infarction 49 11.3 Non-ST-segment elevation acute coronary syndrome 38 57.3 Stable angina 7 31.4 Other 6 0 Patient presentation   Cardiogenic shock 16 --</description><subject>Acute coronary syndromes</subject><subject>Angina pectoris</subject><subject>Blood platelets</subject><subject>Cardiology</subject><subject>Drug dosages</subject><subject>Electrocardiography</subject><subject>FDA approval</subject><subject>Glycoproteins</subject><subject>Heart attacks</subject><subject>Patients</subject><subject>Stents</subject><subject>Surgery</subject><subject>Thrombosis</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkc1u1TAQhS1ERW8LL8ACWWLDogkeO7ZjxOYq9AepEhK0Ymk5zrRy5JsEO7eCt-mz8GQktN2wYjWj0TdHM-cQ8hpYCQzU-77snfclX_oSoGSgn5ENSFkXQhr9nGyYFrIAZvQhOcq5Z4ypGswLcsi1gUoZsyHYuOE2YRwTvc5Iv4XBIz37tP19v52mNN65-IFu1_FtxKLBYcZ0Qr-ii8X3McWOnv6cMAVct9xMHb3CNAeXftHGJaQXY57C7OJLcnDjYsZXj_WYXJ-dXjUXxeWX88_N9rJAweVcGA11LUAyjm0NWPMKW-0N11zWxrQSlFJMas48emMc0612zHRVx6AVN5UQx-Tdg-5y-o895tnuQvYYoxtw3GcLtaoFF8aY_0ArxbhSXC3o23_QftynYXlkFRRSCaZgod48Uvt2h52dUtgtRtgnrxfg4wOAiwN3AZPN_q9zXUjoZ9uNwQKza7S2t2u0do3WAtglWvEHSmGS2w</recordid><startdate>20170131</startdate><enddate>20170131</enddate><creator>Vaduganathan, Muthiah</creator><creator>Qamar, Arman</creator><creator>Singh, Abhayjit</creator><creator>Venkateswaran, Ramkumar V.</creator><creator>Szumita, Paul M.</creator><creator>Croce, Kevin J.</creator><creator>Mauri, Laura</creator><creator>Leopold, Jane A.</creator><creator>Shah, Pinak B.</creator><creator>Sobieszczyk, Piotr</creator><creator>Faxon, David P.</creator><creator>Bhatt, Deepak L.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20170131</creationdate><title>Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital</title><author>Vaduganathan, Muthiah ; Qamar, Arman ; Singh, Abhayjit ; Venkateswaran, Ramkumar V. ; Szumita, Paul M. ; Croce, Kevin J. ; Mauri, Laura ; Leopold, Jane A. ; Shah, Pinak B. ; Sobieszczyk, Piotr ; Faxon, David P. ; Bhatt, Deepak L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e325t-9718831502eb81e824eb7c92725899b5166605720cec99a07b7a09d4d01b3f433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acute coronary syndromes</topic><topic>Angina pectoris</topic><topic>Blood platelets</topic><topic>Cardiology</topic><topic>Drug dosages</topic><topic>Electrocardiography</topic><topic>FDA approval</topic><topic>Glycoproteins</topic><topic>Heart attacks</topic><topic>Patients</topic><topic>Stents</topic><topic>Surgery</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vaduganathan, Muthiah</creatorcontrib><creatorcontrib>Qamar, Arman</creatorcontrib><creatorcontrib>Singh, Abhayjit</creatorcontrib><creatorcontrib>Venkateswaran, Ramkumar V.</creatorcontrib><creatorcontrib>Szumita, Paul M.</creatorcontrib><creatorcontrib>Croce, Kevin J.</creatorcontrib><creatorcontrib>Mauri, Laura</creatorcontrib><creatorcontrib>Leopold, Jane A.</creatorcontrib><creatorcontrib>Shah, Pinak B.</creatorcontrib><creatorcontrib>Sobieszczyk, Piotr</creatorcontrib><creatorcontrib>Faxon, David P.</creatorcontrib><creatorcontrib>Bhatt, Deepak L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vaduganathan, Muthiah</au><au>Qamar, Arman</au><au>Singh, Abhayjit</au><au>Venkateswaran, Ramkumar V.</au><au>Szumita, Paul M.</au><au>Croce, Kevin J.</au><au>Mauri, Laura</au><au>Leopold, Jane A.</au><au>Shah, Pinak B.</au><au>Sobieszczyk, Piotr</au><au>Faxon, David P.</au><au>Bhatt, Deepak L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2017-01-31</date><risdate>2017</risdate><volume>69</volume><issue>4</issue><spage>463</spage><epage>464</epage><pages>463-464</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Overall, 94 patients underwent coronary angiography with the intent of PCI (of whom 88 received >1 stent or balloon angioplasty) for ST-segment elevation myocardial infarction (STEMI) in 49 patients, non-ST-segment elevation acute coronary syndromes (ACS) in 38, and stable angina in 7.  Single-Center Real-World Experience (n = 100) Pooled CHAMPION Trials[low *] (n = 12,475) Demographic characteristics   Age, yrs 64.0 (55-73) 63.0 (55-71) Female 31 27.6 Medical history   Diabetes mellitus 30 29.3 Prior stroke or transient ischemic attack 6 5.2 History of heart failure 13 8.7 History of peripheral artery disease 11 7.1 Indication for cangrelor use   ST-segment elevation myocardial infarction 49 11.3 Non-ST-segment elevation acute coronary syndrome 38 57.3 Stable angina 7 31.4 Other 6 0 Patient presentation   Cardiogenic shock 16 --</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27914699</pmid><doi>10.1016/j.jacc.2016.11.017</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2017-01, Vol.69 (4), p.463-464 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1868323999 |
| source | Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Acute coronary syndromes Angina pectoris Blood platelets Cardiology Drug dosages Electrocardiography FDA approval Glycoproteins Heart attacks Patients Stents Surgery Thrombosis |
| title | Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T23%3A49%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cangrelor%20Use%20Since%20FDA%C2%A0Approval:%20A%20Single-Center,%20Real-World%20Experience%20at%20a%20Tertiary%20Care%20Hospital&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Vaduganathan,%20Muthiah&rft.date=2017-01-31&rft.volume=69&rft.issue=4&rft.spage=463&rft.epage=464&rft.pages=463-464&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2016.11.017&rft_dat=%3Cproquest_pubme%3E1846026626%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1863563061&rft_id=info:pmid/27914699&rft_els_id=S0735109716369339&rfr_iscdi=true |